BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tuleu C. ‘Formulating better medicines for children’ - still paving the road. Int J Pharm. 2012;435:99-100. [PMID: 22641121 DOI: 10.1016/j.ijpharm.2012.05.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Allegaert K. Pediatric clinical pharmacology: an introduction to a series of educational papers. Eur J Pediatr 2013;172:289-92. [DOI: 10.1007/s00431-012-1921-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Walsh J, Mills S. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference. Ther Deliv 2013;4:21-5. [PMID: 23323778 DOI: 10.4155/tde.12.135] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
3 Donaldson M, Goodchild JH, Epstein JB. Sugar content, cariogenicity, and dental concerns with commonly used medications. The Journal of the American Dental Association 2015;146:129-33. [DOI: 10.1016/j.adaj.2014.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Salunke S, Liu F, Batchelor H, Walsh J, Turner R, Ju TR, Tuleu C; European Paediatric Formulation Initiative (EuPFI). European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children. AAPS PharmSciTech 2017;18:257-62. [PMID: 27422653 DOI: 10.1208/s12249-016-0584-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
5 Allegaert K. Neonates need tailored drug formulations. World J Clin Pediatr 2013;2:1-5. [PMID: 25254168 DOI: 10.5409/wjcp.v2.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Ferrarini A, Bianchetti AA, Fossali EF, Faré PB, Simonetti GD, Lava SA, Bianchetti MG. What can we do to make antihypertensive medications taste better for children? Int J Pharm 2013;457:333-6. [PMID: 23906666 DOI: 10.1016/j.ijpharm.2013.07.054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Dixon BJ, Reis C, Ho WM, Tang J, Zhang JH. Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci 2015;16:22368-401. [PMID: 26389893 DOI: 10.3390/ijms160922368] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 14.2] [Reference Citation Analysis]